| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Esperion Therapeutics, Inc. | Director | Stock Option (right to buy) | 20,000 | $32,400 | $1.62 | 26 May 2022 | Direct |
| Esperion Therapeutics, Inc. | Director | Common Stock | 23,449 | $29,194 | $1.24 | 27 May 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ESPR | Esperion Therapeutics, Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 27 May 2022, 16:20 |
| ESPR | Esperion Therapeutics, Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 28 May 2021, 16:19 |